Efg Capital International Corp. »

Alnylam Pharmaceuticals shares owned by Efg Capital International Corp.

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Efg Capital International Corp. from 13F filings

Historical chart of Efg Capital International Corp. investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Efg Capital International Corp. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Efg Capital International Corp.

Quarter filed Position value Share count Share price at filing
2023-06-30 $3.0M 16k 189.94

More positions owned by Efg Capital International Corp.

Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
Verisk Analytics (VRSK)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
Pepsi (PEP)
Cme (CME)
Adobe Systems Incorporated (ADBE)
Tesla Motors (TSLA)
Netflix (NFLX)
JPMorgan Chase & Co. (JPM)

View all positions for Efg Capital International Corp.

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
FMR
Vanguard Group
BlackRock
Capital Research Global Investors
Wellington Management Company
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies

View all funds holding Alnylam Pharmaceuticals